Volitionrx Limited (VNRX) Misses Q1 EPS by 93c
Tweet
Share
E-mailGet Alerts VNRX Hot Sheet
Join SI Premium – FREE
Volitionrx Limited (NYSE: VNRX) reported Q1 EPS of ($0.97), $0.93 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $990 thousand versus the consensus estimate of $2.05 million.
For earnings history and earnings-related data on Volitionrx Limited (VNRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight
- Barclays Upgrades INWIT (INW:IM) to Overweight
- UBS Downgrades Banco Santander Brasil SA (SANB11:BZ) (BSBR) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
